Rating Change
Leerink Partners reiterated its Outperform rating on CVS Health Corporation (NYSE:CVS) on October 12, 2026.
reiterateNYSE:CVS
Leerink Partners Reiterates Outperform Rating on CVS Health Corporation (CVS)
Leerink Partners reiterated its Outperform rating on CVS Health Corporation (NYSE:CVS) on October 12, 2026.
At publication ·
What changed
CVS Health Corporation (NYSE:CVS) · reiterate
- Firm
- Leerink Partners
- Rating
- Outperform to Outperform
- Price at event
- $87.74
- Market capitalization
- $102.6B
At a glance
Key takeaways
- Leerink Partners reiterated an Outperform rating on CVS Health on October 12, 2026, with the stock trading at $87.74.
Market Context
CVS Health Corporation operates in the Healthcare sector. The stock currently trades at $87.74 with a market capitalization of $102.6B. The stock has gained 8.9% over the past 52 weeks.
Analyst coverage from Leerink Partners provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for CVS Health Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for CVS Health Corporation
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 12, 2026 | Leerink Partners | Outperform | N/A |
| Sep 03, 2026 | UBS | Buy | N/A |
| Aug 19, 2026 | Argus Research | Buy | N/A |
| Aug 12, 2026 | JP Morgan | Overweight | N/A |
| Aug 06, 2026 | Evercore ISI Group | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View CVS Stock Page
Frequently Asked Questions
What does the Outperform rating mean for CVS?
A rating of Outperform from Leerink Partners reflects the analyst's outlook on CVS Health Corporation (NYSE:CVS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CVS forecast page.
